Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor

OBJECTIVES: Traditional cancer therapy and regular immunotherapy are ineffective for treating triple‐negative breast cancer (TNBC) patients. Recently, chimeric antigen receptor‐engineered natural killer cells (CAR NK) have been applied to target several hormone receptors on different cancer cells to...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cell Prolif
Glavni autori: Liu, Yan, Zhou, Yehui, Huang, Kuo‐Hsiang, Fang, Xujie, Li, Ying, Wang, Feifei, An, Li, Chen, Qingfei, Zhang, Yunchao, Shi, Aihua, Yu, Shuang, Zhang, Jingzhong
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445407/
https://ncbi.nlm.nih.gov/pubmed/32592435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12858
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items